Context There is substantial evidence that reduced short-chain fatty acids (SCFAs) in the gut
are associated with obesity and type 2 diabetes, although findings from clinical interventions …

The Western diet is associated with gastrointestinal dysbiosis, an active contributor to the
pathophysiology of obesity and its comorbidities. Gastrointestinal dysbiosis is strongly linked …

Background The outcomes of bariatric surgery (BS) in patients with chronic inflammatory
bowel disease (IBD) remain rarely described. We aimed to evaluate the 90-day morbidity …

Abstract Background The Roux-en-Y gastric bypass (RYGB) is a common bariatric surgery
to treat obesity. Its metabolic consequences are favourable and long-term clinical corollaries …

Background Mechanisms mediating hypertensive effects of overweight and obesity have not
been fully elucidated. We showed previously that activation of pregnane X receptor (PXR) by …

Gastrointestinal dysbiosis is common among persons with type 1 diabetes (T1D), but its
potential impact on diabetic nephropathy (DN) remains obscure. We examined whether …

Obesity is a multifactorial, chronic, progressive and recurrent disease considered a public
health issue worldwide and an important determinant of disability and death. In Spain, its …

Obesity is a chronic, relapsing, progressive disease of excess adiposity that increases the
risk of developing at least 13 types of cancer. This report provides a concise review of the …

Obesity is associated with low‐grade inflammation and increased systemic oxidative stress.
Roux‐en‐Y gastric bypass (RYGB) surgery is known to ameliorate the obesity‐induced …

Background Bariatric surgery is an effective intervention that causes a series of metabolic
changes related to inflammatory processes; however, the variation of biomarkers related to …